Dr Gary Nabel | Chief Scientific Officer And Senior Vice President Head, North America R&D Hub
Sanofi Pasteur

Plenary, April 7 @ 17:50

Real use of next generation approaches into new vaccines: Role of human mABs for discovery, therapy, and vaccine acceleration

• Exploring new non-traditional vaccine technologies and progression from passive immunity
• Using mAbs to accelerate vaccine development by anticipating some of the key biological and regulatory questions
• Use of adjuvants and safety

Dr Gary Nabel, Chief Scientific Officer And Senior Vice President Head, North America R&D Hub, Sanofi Pasteur

Sanjay Phogat, Vice President R&D, Head Dpu, Italy, GSK

×

Sanjay Phogat / Real use of next generation approaches into new vaccines: Role of human mABs for discovery, therapy, and vaccine acceleration

Sanjay Phogat, Vice President R&D, Head Dpu, Italy,
GSK

Since March 2019, Sanjay has been responsible of the Discovery Performance Unit of the Italian Research & Development Center, leader in discovery and development of vaccines and human monoclonals. He has 20 years of experience in R&D with roles of increasing responsibility as Head of Mab...

CloseMore